Joachim Kreuzburg, Former CEO of Sartorius, Joins Cube Biotech’s Board of Directors
Advertisement
Cube Biotech GmbH announced the appointment of Dr. Joachim Kreuzburg, former CEO and Chairman of the Executive Board of Sartorius AG, to its Board of Directors, effective July 3rd, 2025.
Dr. Kreuzburg brings over two decades of executive leadership in the life sciences industry. During his tenure as CEO of Sartorius (2003–2025), the company expanded from a regional player into a global leader in bioprocessing, growing revenue from approximately €0.5 billion to approximately €3.5 billion and increasing the market capitalization of the group by a factor of approximately 150.
“We are honored to welcome Joachim to the Cube Biotech Board,” said Didier Dargent, Executive Chairman of Cube Biotech. “His strategic insights and deep sector expertise will be invaluable as we scale our global operations and advance our automation-driven capabilities in membrane protein technologies, purification and drug discovery.”
Dr. Kreuzburg added: “Cube Biotech is building a powerful platform with world-class science, strong momentum, and an entrepreneurial team. I am excited to join the Board and support its journey to become a global leader in protein research.”
Most read news
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Prize for bioconversion of renewable raw materials - Daniel Eggerichs has bacteria produce plastic precursors from paper production waste
LenioBio announces new CEO - Founder will be stepping down as CEO
T-CURX announces senior leadership appointments - T-CURX completes formation of highly experienced clinical team to rapidly advance clinical translation of its next-generation CAR-T cell therapies
Samanta Cimitan Appointed Chief Executive Officer (CEO) at Celonic
BioGaia appoints Theresa Agnew as new CEO
EVIDENT Corporation Appoints New CEO and COO
Danaher appoints Christopher Riley to Executive Vice President for Biotechnology
Biotage AB appointment of new CEO
Dr. Christine Munz becomes CEO at Eppendorf - Dr. Wilhelm Plüster completes term in office as planned
Beckman Coulter Life Sciences Names Joe Fox President
Nobel Prize in Medicine for immune system guardians - Two Americans and one Japanese scientist honored for revolutionary discoveries on the balance of the immune system in autoimmune diseases